4.2 Review

Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

O. A. Cornely et al.

CLINICAL MICROBIOLOGY AND INFECTION (2014)

Review Microbiology

Mucormycosis treated with posaconazole: review of 96 case reports

Joerg J. Vehreschild et al.

CRITICAL REVIEWS IN MICROBIOLOGY (2013)

Article Immunology

Combination Therapy for Mucormycosis: Why, What, and How?

Brad Spellberg et al.

CLINICAL INFECTIOUS DISEASES (2012)

Article Immunology

A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)

F. Lanternier et al.

CLINICAL INFECTIOUS DISEASES (2012)

Article Infectious Diseases

Fatal bronchial invasion of Scopulariopsis brevicaulis in an acute monocytic leukemia patient

Qing Yang et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)

Article Infectious Diseases

In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus

Suganthini Krishnan-Natesan et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)

Article Hematology

Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination

Rafael Rojas et al.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2012)

Article Microbiology

Combination Therapy of Murine Mucormycosis or Aspergillosis with Iron Chelation, Polyenes, and Echinocandins

Ashraf S. Ibrahim et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

Article Infectious Diseases

Treatment of murine Fusarium verticillioides infection with liposomal amphotericin B plus terbinafine

Mery Ruiz-Cendoya et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)

Article Microbiology

International Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole

Olivier Lortholary et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Article Infectious Diseases

Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009

Marcela Campo et al.

JOURNAL OF INFECTION (2010)

Article Microbiology

Interactions between Triazoles and Amphotericin B in Treatment of Disseminated Murine Infection by Fusarium oxysporum

Mery Ruiz-Cendoya et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Article Microbiology

Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis

Brad Spellberg et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Article Microbiology

Anidulafungin in Combination with Amphotericin B against Aspergillus fumigatus

Elisabetta Spreghini et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Letter Microbiology

Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis

Alexis Soummer et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)

Article Immunology

Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis

Caitlin Reed et al.

CLINICAL INFECTIOUS DISEASES (2008)

Article Infectious Diseases

In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.

Susana Cordoba et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)

Article Oncology

Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia

Annelies M. Zwitserloot et al.

PEDIATRIC BLOOD & CANCER (2008)

Article Medicine, Research & Experimental

The iron chelator deferasirox protects mice from mucormycosis through iron starvation

Ashraf S. Ibrahim et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Microbiology

Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro

Susanne Perkhofer et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)

Article Infectious Diseases

Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species

Elizabeth M. O'Shaughnessy et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)

Letter Microbiology

Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis

Caitlin Reed et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)

Article Microbiology

Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole

G Chamilos et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)

Review Infectious Diseases

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist

Josep Guarro et al.

MEDICAL MYCOLOGY (2006)

Article Oncology

Successful antifungal combination therapy with voriconazole and caspofungin

F Schuster et al.

PEDIATRIC BLOOD & CANCER (2005)

Article Oncology

Acremonium pyomyositis in a pediatric patient with acute leukemia

YH Chang et al.

PEDIATRIC BLOOD & CANCER (2005)

Review Infectious Diseases

Human fusariosis

MC Dignani et al.

CLINICAL MICROBIOLOGY AND INFECTION (2004)

Article Immunology

Combination antifungal therapy for invasive aspergillosis

KA Marr et al.

CLINICAL INFECTIOUS DISEASES (2004)

Article Microbiology

Differentiation of Rhizomucor species on the basis of their different sensitivities to lovastatin

G Lukács et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2004)

Article Dentistry, Oral Surgery & Medicine

Fatal necrotizing stomatitis due to Trichoderma longibrachiatum in a neutropenic patient with malignant lymphoma:: a case report

Y Myoken et al.

INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2002)